Risankizumab

About

Thing
Risankizumab is a humanized monoclonal antibody targeting interleukin 23A. Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.
Risankizumab
Definition
Risankizumab is a humanized monoclonal antibody targeting interleukin 23A. Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.
Risankizumab
Risankizumab
Risankizumab is a humanized monoclonal antibody targeting interleukin 23A. Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.

Pronunciation

English

Risankizumab

Risankizumab
SpellingRisankizumab
Pronunciation[Risankizumab]
New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.

See also: